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Target setting has been useful for both the National 
Department of Health (NDoH) and supporting 
partners to plan, assess and improve the current 
performance of HIV testing and antiretroviral 
treatment (ART) programmes. Various models for 
estimating HIV testing and ART initiation need and coverage in 
South Africa (SA) have been popularised.[1-4] However, less attention 
has been afforded to models which enable programme managers to 
effectively understand and plan for the ART need based on the local 
context, i.e. district and sub-district needs over the long term. 
In the last 4 years, the ART initiation environment in SA has 
changed substantially due to policy amendments related to the 
roll-out of nurse-initiated management of ART,[5] and the change in 
the recommended CD4+ count threshold for initiation of ART, i.e. 
a shift from <200 cells/μl to <350 cells/μl.[6] There remains a need 
for simple, practical tools which can be understood and applied 
at a local level to enable district planners to accurately plan and 
evaluate their HIV testing and ART programmes on an ongoing 
basis. Planning for both the sick and currently well sections of the 
HIV population in need of ART is imperative to ensure that the 
appropriate resources, including drugs, are allocated and utilised 
efficiently and effectively. Furthermore, planning should account 
for current performance relative to national and district-level 
targets. Leydon et al.[1] proposed a model which uses local target 
setting in district healthcare facilities, accounting for the backlog of 
clients needing treatment. 
We propose that the current ART need in SA can be planned for 
in terms of an annual ‘steady-state’ that adds new clients each year, 
and a single pool (‘backlog’) of currently asymptomatic patients who 
are eligible for treatment by virtue of the change in guidelines from a 
CD4+ count threshold of <200 cells/μl to <350 cells/μl. The healthcare 
system response is different for these two categories. Experience in 
supporting districts has shown that although some districts may meet 
their annual ‘steady-state’ ART initiation targets, districts have yet to 
meet the backlog need for ART created by the shift in CD4+ count 
thresholds. 
Objectives
With the district health information system as a source, we used 
routine observational data from ART programmes in a North West 
Province (NWP) district[7] to describe and illustrate the use of a 
target-setting model for estimating district-based targets in the era of 
an expanding ART programme and changing CD4+ count thresholds 
for ART initiation.
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Background. Target setting is useful in planning, assessing and improving antiretroviral treatment (ART) programmes. In the past 4 years, 
the ART initiation environment has been transformed due to the change in eligibility criteria (starting ART at a CD4+ count <350 cells/μl v. 
<200 cells/μl) and the roll-out of nurse-initiated management of ART. 
Objective. To describe and illustrate the use of a target-setting model for estimating district-based targets in the era of an expanding ART 
programme and changing CD4+ count thresholds for ART initiation.
Method. Using previously described models and data for annual new HIV infections, we estimated both steady-state need for ART initiation 
and backlog in a North West Province district, accounting for the shift in eligibility. Comparison of actual v. targeted ART initiations was 
undertaken. The change in CD4+ count threshold adds a once-off group of newly eligible patients to the pool requiring ART – the backlog. 
The steady-state remains unchanged as it is determined by the annual rate of new HIV infections in previous years. 
Results. The steady-state need for the district was 639 initiations/month, and the backlog was ~15 388 patients. After the shift in eligibility 
in September 2011, the steady-state target was exceeded over several months with some backlog addressed. Of the total backlog for this 
district, 72% remains to be cleared.
Conclusion. South Africa has two pools of patients who need ART: the steady-state of HIV-infected patients entering the programme each 
year, determined by historical infection rates; and the backlog created by the shift in eligibility. The healthcare system needs to build long-
term capacity to meet the steady-state need for ART and additional capacity to address the backlog. 
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Methods
Using two previously described models 
and tools developed by the Institute for 
Healthcare Improvement and the Wits 
Reproductive Health and HIV Institute, we 
estimated the steady-state and backlog need 
for ART initiation in a NWP district resulting 
from the shift in CD4+ count thresholds.[1,2]
These were calculated on the basis of a 
district population of 695 933[8] and antenatal 
HIV prevalence of 32.4%[9] 
Ethics approval was obtained from 
the Human Research Ethics Committee 
(Medical), University of the Witwatersrand 
(clearance no. M130206). 
Steady-state calculation
The previously published highly active 
antiretroviral therapy (HAART) calculator 
is used to determine the steady-state need 
for ART initiations.[2] This determines the 
number of incoming clients eligible for ART 
to be added to the programme each year, 
based on Actuarial Society of South Africa 
estimates for new HIV infections in previous 
years. It is estimated that it will take 5 years 
from the time of HIV acquisition to the 
time that an HIV-infected person’s CD4+ cell 
count falls below 350 cells/μl, making him/
her eligible for ART.[10] We used a simplified 
model to determine the steady-state for ART 
initiation prior to the change in CD4+ count 
thresholds, which assumed that patients with 
CD4+ counts of <200 cells/μl are started on 
ART or die. Patients with CD4+ counts of 200 
- 350 cells/μl are started on ART, stay alive in 
the backlog ‘pool’ until they are started on 
treatment or die.
As described by Leydon et al.,[1] the steady-
state need for ART initiation is determined 
by the historical annual infection rates 
and is not influenced by a change in CD4+ 
count thresholds. The change in CD4+ 
count thresholds does create a backlog, i.e. 
a one-time pool of additional patients with 
CD4+ counts 200 - 350 cells/µl who require 
ART. However, once this additional pool 
of patients has been initiated on ART, the 
annual requirements of the healthcare system 
for initiating new patients on treatment 
returns to a steady-state that is determined 
by new HIV infections in previous years.[1] 
Backlog calculation
The change in ART initiation criteria 
results in a shortened interval from HIV 
acquisition to ART initiation: from 7 years 
if the threshold is 200 cells/μl to 5 years if 
the threshold is 350 cells/μl.[10] In the year 
that the CD4+ count threshold changes, 
an additional set of patients needing ART 
is added to the pool – in this case, an 
additional 2 years’ worth of the steady-state 
need. This is the backlog. The model for 
calculating SA’s steady-state and backlog is 
shown in Fig. 1. In this model, the system 
was at steady-state in 2010 when the CD4+ 
count threshold was 200 cells/µl. In that 
year in SA, ~500 000 patients infected in 
2003[11] needed treatment. In 2011, the CD4+ 
count threshold increased to 350 cells/µl, 
adding the backlog of patients from the 
2004 and 2005 cohorts, which each added 
500 000 patients to the pool, as well as the 
new steady-state influx of 500 000 patients 
from the 2006 cohort. In 2012, if the backlog 
was eliminated, the steady-state conditions 
returned with 500 000 added from the 2007 
cohort. 
Using observational data at a district level, 
the proposed model was then applied to 
generate estimates of actual ART initiations 
in the district as compared with the steady-
state and backlog targeted ART initiations 
as determined by the methods outlined 
above. In doing so, we propose that target 
setting at a district level incorporates two 
distinct steps: (i) the steady-state calculation; 
and (ii) the backlog estimate resulting in a 
comprehensive and more accurate district 
ART target.
Results
For this NWP district, the steady-state need 
was calculated at 639 initiations/month 
(7 669 per year). The backlog need created 
by the change in CD4+ count threshold was 
~15 388 patients. Since September 2011, after 
the shift in CD4+ count threshold, the steady-
state target was exceeded over several months. 
In those months, the backlog was decreased 
by the number of patients started on ART in 
excess of the steady-state target. The model 
assumes that ART initiations below the 
targeted steady-state threshold are initiations 
in patients with CD4+ counts <200 cells/μl 
and that ART initiations above the steady-
state target are initiations in patients with 
CD4+ counts between 200 cells/μl and 
350 cells/μl. In months where initiations fell 
below the steady-state target, the backlog was 
not affected. Using these assumptions, the 
backlog was decreased by 3 335 initiations 
during months when the steady-state target 
was exceeded. The backlog was not affected 
when the initiation rate dropped below the 
steady-state target, since the great majority 
of patients treated under these conditions 
were assumed to have a CD4+ count of 
<200 cells/ μl. Of the backlog, 72% remained, 
meaning that in this NWP district, ~12 000 of 
the projected 15 300 patients remained in the 
backlog pool awaiting initiation onto ART. 
Fig. 2 depicts the relationship between actual 
ART monthly initiations, the steady-state 
monthly initiation target and backlog (CD4+ 
count 200 - 350 cells/µl) for the district. Actual 
ART initiations in the district were compared 
with targeted steady-state need. In the months 
where ART initiations exceeded the steady-
state target, the backlog was reduced; however, 
during months where the steady-state target 
was not met, the backlog remained static. 
Discussion
Practical tools and models that facilitate target 
setting at a district level enhance the response 
to the HIV epidemic. SA has two pools 
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Fig. 1. A model for calculating South Africa’s steady-state and backlog need for antiretroviral treatment 
(ART) initiation. Estimated number of new patients requiring ART initiation in 2010 (based on 
CD4+ count threshold of 200 cells/µl), 2011 (during transition to new threshold of 350 cells/µl) and 
2012, assuming that the backlog created by the shift in eligibility is cleared. (HAART = highly active 
antiretroviral therapy; 500k = 500 000.)
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of HIV patients who need ART. Firstly, as 
described previously, there is a steady-state 
rate of HIV-infected patients who should be 
entering the ART programme each year. This 
is determined by the annual rate of new HIV 
infections in previous years. Secondly, a shift 
in the CD4+ count threshold causes a one-
time additional backlog that is quantifiable 
and can be addressed by a temporary increase 
in system capacity. When steady-state rates 
are exceeded, the backlog can be worked 
down. Using this model, we estimated that in 
this NWP district the backlog decreased by 
27% during the months when initiation rates 
exceeded the steady-state rate. Understanding 
the different approaches for steady-state and 
backlog initiations is needed to appropriately 
respond to the HIV care and treatment needs 
in each district. Each requires a different 
planning response. 
Translated to SA as a whole, the healthcare 
system needs to build reliable long-
term capacity to initiate and care for the 
~500 000 new patients per year generated 
by infections in past years. This annual 
number is expected to decrease in future 
years due to the declining annual infection 
rate (estimated 320 000 in 2012).[11] But the 
healthcare system also needs to be able to 
temporarily increase capacity to address the 
backlog of an additional one million patients 
in need of ART (Fig. 1) created by changes 
in the CD4+ count threshold. In addition, 
system planners need to build capacity to 
meet long-term chronic care needs of all of 
those started on ART each year. 
The most recent data on ART initiation 
(~500 000 per year)[12] suggest that SA is only 
providing sufficient ART initiation capacity 
to meet its steady-state needs. The projected 
additional one million patients who need 
treatment will undoubtedly place tremendous 
strain on the already overburdened healthcare 
system, which will need to add even greater 
capacity following any further increase in the 
CD4+ count threshold. 
Study limitations 
The proposed model is based on assump-
tions that introduce some limitations to 
generalisability of the findings. 
The model is based on estimates regarding 
population size, antenatal prevalence and 
ART initiation numbers. The number of new 
infections has decreased over the past 5 years 
from a high of 530 000 in 2006 to 320 000 in 
2012.[11] This means that the model, based 
on an average infection rate of 500 000 per 
year, overestimates the steady-state need 
for future years. The model is simplistic 
in terms of its assumptions regarding the 
average time from HIV infection to ART 
need depending on CD4+ count thresholds, 
the consequences of not initiating ART at 
these thresholds, and the assumed CD4+ 
counts of individuals who are being initiated 
on ART when the initiation targets are below 
or exceed the steady-state targets. The model 
has not included in the target the estimated 
400 000 HIV-infected pregnant women who 
need to receive antiretrovirals each year for 
the duration of pregnancy and breastfeeding, 
since these women are only transiently added 
to the pool of treated HIV-infected patients 
under the current NDoH policy. The policy 
to initiate all tuberculosis patients on ART 
will further add to the pool of patients in 
the backlog. Further, the model assumes that 
those patients who are lost to follow-up will 
either die or re-enter the treatment pool at a 
later date and are therefore not added back 
into the backlog estimate. 
Conclusion
This paper highlights and describes a 
practical model for setting targets for ART 
initiation that can be applied at all levels 
of the healthcare system. It highlights the 
distinction between the steady-state need for 
ART initiation, and the backlog need created 
by changes in CD4+ count thresholds. Any 
further increase in the CD4+ count threshold 
with future World Health Organization 
recommendations would add further 
patients to the backlog, again with no effect 
on the steady-state requirements. Despite 
the limitations of the model, its simplicity 
allows it to have practical application and to 
provide a support tool to district planners in 
terms of the ART programme. Appropriate 
planning for the ART need, in a changing 
environment, is imperative to ensuring that 
targets are met, and that all eligible patients 
are identified, are able to access care and are 
initiated on ART. 
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Fig. 2. The relationship between backlog and exceeding the steady-state target for the North West 
Province district. (ART = antiretroviral treatment.)
